サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1540855

フローサイトメトリー市場レポート：製品・サービス、技術、用途、エンドユーザー、地域別、2024～2032年

Flow Cytometry Market Report by Product and Service, Technology, Application, End-User, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 142 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.89円
フローサイトメトリー市場レポート：製品・サービス、技術、用途、エンドユーザー、地域別、2024～2032年
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 142 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のフローサイトメトリー市場規模は2023年に58億米ドルに達しました。今後、IMARC Groupは、2024～2032年にかけての成長率（CAGR）は7.2％を示し、2032年までに市場は110億米ドルに達すると予測しています。個別化医療における製品採用の広がり、ライフサイエンスとバイオテクノロジーにおける研究活動の拡大、学術研究機関への資金提供の加速は、市場を推進する主要要因の一部です。

フローサイトメトリーは、異種集団内の個々の細胞の詳細なマルチパラメーター分析を可能にする技術です。この技術は、光を用いて細胞や粒子の集団の物理的・化学的特性を検出・測定します。各粒子は液体に懸濁され、電子検出装置に通されます。光のビームがストリームに照射され、光の散乱が粒子とその特性の特徴になります。これらのパターンの強度を利用して、各細胞の物理的・化学的構造に関するさまざまな種類のデータを導き出すことができます。この情報は、診断や生物医療研究など、幅広い用途で価値があります。毎秒数千個の粒子を素早く分析し、1つの細胞の複数のパラメーターに関するデータを同時に収集することができます。そのため、細胞生物学や医療において不可欠なツールとなっています。

生命科学とバイオテクノロジーにおける研究活動の拡大が、世界市場を大きく牽引しています。細胞生物学、免疫学、腫瘍学研究における重要なツールです。細胞周期や増殖、アポトーシス、その他の細胞機能の研究に広く使用されています。これらの研究セグメント、特に新興諸国における投資の増加は、これらの機器、試薬、ソフトウェアの需要に影響を与えています。さらに、病気の検出とモニタリングにおけるこれらの方法の精度と効率は、個別化医療に理想的です。この医療モデルの採用が増え続けていることが、市場の成長を大きく後押ししています。これとは別に、学術・研究機関、特に細胞ベースの研究に従事する機関への資金援助が加速していることも、市場を大きく牽引しています。これらの資金は、先進的なサイトメトリー技術の購入や新しい用途の開拓を容易にし、市場全体の成長を促進しています。さらに、早期診断と治療法の利点に対する認識が加速していることと、中間層の人口が増加していることが、市場の展望を明るいものにしています。

フローサイトメトリー市場傾向/促進要因

慢性疾患の増加

がん、HIV/AIDS、その他の免疫系関連疾患などの慢性疾患の罹患率の上昇が、フローサイトメトリーの需要を大幅に押し上げています。これに伴い、フローサイトメトリーはいくつかの血液学的悪性腫瘍の診断と予後に不可欠であり、疾患の進行と治療反応のモニタリングにますます使用されるようになっています。世界の人口が高齢化し、このような疾患の有病率が増加するにつれて、迅速で正確な診断とモニタリングツールの必要性も高まっています。その結果、効果的な治療を提供し、患者のQOLを向上させるための医療セクターの継続的な取り組みが、フローサイトメトリー市場の重要な原動力となっています。

臨床試験と創薬における採用の増加

臨床試験や創薬においてフローサイトメトリー法が広く採用されていることは、市場の重要な促進要因です。さらに、個々の細胞や細胞集団に関する詳細な情報を提供できるフローサイトメトリーの能力は、薬効評価や潜在的な治療標的の同定に理想的です。これとは別に、製薬会社は新薬の安全性と有効性を評価するための前臨床試験や臨床試験において、ますますこれらの手法に頼るようになっています。そのため、市場にプラスの影響を与えています。製薬業界の拡大と新薬候補の増加により、この領域におけるフローサイトメトリーの需要は大幅に加速しており、市場全体の成長を牽引しています。

継続的な技術進歩

フローサイトメトリー業界の市場促進要因の一つは、このセグメントにおける継続的な技術進歩です。高スループットフローサイトメトリーの出現、より優れたデータ解析を提供するソフトウェアソリューションの進歩、特異的なプローブや試薬の開発により、フローサイトメトリーの有効性は著しく向上しました。さらに、コンパクトでユーザーフレンドリー、かつ手頃な価格のシステムの導入は、この技術の民主化につながり、その使用範囲は研究所から臨床現場、さらにはポイントオブケア診断にまで拡大しました。また、多くのパラメーターを同時に検出できるマルチカラーアッセイや試薬も増加し、その能力はさらに向上しています。これらの進歩は、より効率的で信頼性の高い結果をもたらすだけでなく、潜在的な応用範囲を広げ、市場の成長に寄与しています。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界のフローサイトメトリー市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品・サービス別

  • 機器
  • 試薬と消耗品
  • 付属品
  • ソフトウェア
  • サービス

第7章 市場内訳：技術別

  • 細胞ベースのフローサイトメトリー
  • ビーズベースのフローサイトメトリー

第8章 市場内訳：用途別

  • 腫瘍学
  • 創薬
  • 病気の診断
  • 幹細胞療法
  • 臓器移植
  • 血液学
  • その他

第9章 市場内訳：エンドユーザー別

  • 病院とクリニック
  • 学術研究機関
  • 製薬・バイオテクノロジー企業
  • その他

第10章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Agilent Technologies Inc.
    • Apogee Flow Systems Ltd.
    • BD（Becton, Dickinson and Company）
    • Beckman Coulter Inc.（Danaher Corporation）
    • Bio-RAD Laboratories Inc.
    • Enzo Life Sciences Inc.
    • Luminex Corporation
    • Merck KGaA
    • Sony Biotechnology Inc.
    • Sysmex Partec GmbH
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Flow Cytometry Market: Major Drivers and Challenges
  • Figure 2: Global: Flow Cytometry Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Flow Cytometry Market: Breakup by Product and Service (in %), 2023
  • Figure 4: Global: Flow Cytometry Market: Breakup by Technology (in %), 2023
  • Figure 5: Global: Flow Cytometry Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Flow Cytometry Market: Breakup by End-User (in %), 2023
  • Figure 7: Global: Flow Cytometry Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Flow Cytometry Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 9: Global: Flow Cytometry (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Flow Cytometry (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Flow Cytometry (Reagents and Consumables) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Flow Cytometry (Reagents and Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Flow Cytometry (Accessories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Flow Cytometry (Accessories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Flow Cytometry (Software) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Flow Cytometry (Software) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Flow Cytometry (Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Flow Cytometry (Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Flow Cytometry (Cell-Based) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Flow Cytometry (Cell-Based) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Flow Cytometry (Bead-Based) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Flow Cytometry (Bead-Based) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Flow Cytometry (Oncology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Flow Cytometry (Oncology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Flow Cytometry (Drug Discovery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Flow Cytometry (Drug Discovery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Flow Cytometry (Disease Diagnosis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Flow Cytometry (Disease Diagnosis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Flow Cytometry (Stem Cell Therapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Flow Cytometry (Stem Cell Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Flow Cytometry (Organ Transplantation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Flow Cytometry (Organ Transplantation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Flow Cytometry (Hematology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Flow Cytometry (Hematology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Flow Cytometry (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Flow Cytometry (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Flow Cytometry (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Flow Cytometry (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Flow Cytometry (Academic and Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Flow Cytometry (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Global: Flow Cytometry (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Global: Flow Cytometry (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Global: Flow Cytometry (Other End-Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Global: Flow Cytometry (Other End-Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: North America: Flow Cytometry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: North America: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: United States: Flow Cytometry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: United States: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Canada: Flow Cytometry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Canada: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Asia Pacific: Flow Cytometry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Asia Pacific: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: China: Flow Cytometry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: China: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Japan: Flow Cytometry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Japan: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: India: Flow Cytometry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: India: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: South Korea: Flow Cytometry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: South Korea: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Australia: Flow Cytometry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Australia: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Indonesia: Flow Cytometry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Indonesia: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Others: Flow Cytometry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Others: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Europe: Flow Cytometry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Europe: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Germany: Flow Cytometry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Germany: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: France: Flow Cytometry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: France: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: United Kingdom: Flow Cytometry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: United Kingdom: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Italy: Flow Cytometry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Italy: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Spain: Flow Cytometry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Spain: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Russia: Flow Cytometry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Russia: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Others: Flow Cytometry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Others: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Latin America: Flow Cytometry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Latin America: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Brazil: Flow Cytometry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Brazil: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Mexico: Flow Cytometry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 88: Mexico: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Others: Flow Cytometry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 90: Others: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 91: Middle East and Africa: Flow Cytometry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 92: Middle East and Africa: Flow Cytometry Market: Breakup by Country (in %), 2023
  • Figure 93: Middle East and Africa: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 94: Global: Flow Cytometry Industry: SWOT Analysis
  • Figure 95: Global: Flow Cytometry Industry: Value Chain Analysis
  • Figure 96: Global: Flow Cytometry Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Flow Cytometry Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Flow Cytometry Market Forecast: Breakup by Product and Service (in Million US$), 2024-2032
  • Table 3: Global: Flow Cytometry Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 4: Global: Flow Cytometry Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Flow Cytometry Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 6: Global: Flow Cytometry Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Flow Cytometry Market: Competitive Structure
  • Table 8: Global: Flow Cytometry Market: Key Players
目次
Product Code: SR112024A2272

The global flow cytometry market size reached US$ 5.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.0 Billion by 2032, exhibiting a growth rate (CAGR) of 7.2% during 2024-2032. The widespread product adoption in personalized medicine, the expansion of research activities in life sciences and biotechnology, and the accelerating funding for academic and research institutes are some of the major factors propelling the market.

Flow cytometry is a technology that allows detailed multi-parameter analysis of individual cells within a heterogeneous population. This technique uses light to detect and measure physical and chemical properties of a population of cells or particles. Each particle is suspended in a stream of fluid and passed through an electronic detection apparatus. A beam of light is directed onto the stream, and the light scatter is characteristic of the particles and their properties. The intensity of these patterns can be used to derive various types of data about the physical and chemical structure of each cell. This information is valuable in a wide range of applications, including diagnostics and biomedical research. It can quickly analyze thousands of particles per second and concurrently gather data about multiple parameters of a single cell. Therefore, it is an essential tool in cell biology and medicine.

The expansion of research activities in life sciences and biotechnology majorly drives the global market. It is a crucial tool in cell biology, immunology, and oncology research. It is extensively used in the study of cell cycle and proliferation, apoptosis, and other cellular functions. The rising investments in these research areas, especially in developing countries, have influenced the demand for these instruments, reagents, and software. In addition, the precision and efficiency of these method in the detection and monitoring of diseases make it ideal for personalized medicine. As this medical model continues to rise in adoption, it is significantly driving the growth of the market. Apart from this, the accelerating funding for academic and research institutes, particularly those engaged in cell-based research, has been a considerable driver for the market. These funds facilitate the purchase of advanced cytometry technologies and the development of new applications, driving the overall market growth. Moreover, the accelerating awareness about the benefits of early diagnosis and therapeutics, coupled with a growing middle-class population is creating a positive market outlook.

Flow Cytometry Market Trends/Drivers:

Increasing Prevalence of Chronic Diseases

The rising incidence of chronic diseases such as cancer, HIV/AIDS, and other immune system-related diseases has substantially driven the demand for flow cytometry. Along with this, flow cytometry is indispensable in the diagnosis and prognosis of several hematological malignancies and is increasingly being used in monitoring disease progression and treatment response. As the global population ages and the prevalence of such diseases increases, the need for fast, accurate diagnostic and monitoring tools also grows. Consequently, the healthcare sector's ongoing efforts to provide effective treatments and improve patients' quality of life act as a significant driving force for the flow cytometry market.

Increased Adoption in Clinical Trials and Drug Discovery

The widespread adoption of the method in clinical trials and drug discovery is a significant market driver. In addition, flow cytometry's ability to provide detailed information about individual cells and cellular populations makes it ideal for evaluating drug effects and identifying potential therapeutic targets. Apart from this, pharmaceutical companies are increasingly relying on these methods for preclinical testing and clinical trials to assess the safety and efficacy of new drugs. Therefore, it is positively influencing the market. With the expanding pharmaceutical industry and escalating number of new drug candidates, the demand for flow cytometry in this domain is accelerating substantially, driving the overall growth of the market.

Continuous Technological Advancements

One of the primary market drivers for the flow cytometry industry is the continued technological advancements in this field. The emergence of high-throughput flow cytometry, advancement in software solutions that offer better data analysis, and development of specific probes and reagents have significantly improved the efficacy of flow cytometry. Additionally, the introduction of compact, user-friendly, and affordable systems has led to the democratization of this technology, expanding its use from research labs to clinical settings and even point-of-care diagnostics. There has also been a rise in multicolor assays and reagents which allow simultaneous detection of many parameters, further enhancing the capabilities. These advancements not only provide more efficient and reliable results but also widen the range of potential applications, thereby contributing to the growth of the market.

Flow Cytometry Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global flow cytometry market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on product and service, technology, application and end-user.

Breakup by Product and Service:

Instruments

Reagents and Consumables

Accessories

Software

Services

Instruments dominate the market

The report has provided a detailed breakup and analysis of the market based on the product and service. This includes instruments, reagents and consumables, accessories, software, and services. According to the report, instruments represented the largest segment.

In the industry, market drivers for instruments and services are multifaceted. As instruments become more precise, user-friendly, and affordable, they facilitate an expanded range of applications, thus driving demand. In addition, the development of portable and benchtop flow cytometers has made the technology more accessible, boosting the sales of these instruments. Services related to flow cytometry, such as maintenance, training, and data analysis, also experience increased demand driven by the growing usage of this method in various sectors. The complexity of the method data requires specialized software and skilled professionals for analysis, making these services critical. As more businesses and research institutions adopt flow cytometry, they often seek out these services to ensure effective operation and accurate results, further propelling the market for these services.

Breakup by Technology:

Cell-Based Flow Cytometry

Bead-Based Flow Cytometry

Cell-based flow cytometry dominates the market

A detailed breakup and analysis of the market based on the technology have also been provided in the report. This includes cell-based flow cytometry and bead-based flow cytometry. According to the report, cell-based flow cytometry represented the largest segment.

The market for cell-based technology in the industry is driven by the increasing incidence of diseases such as cancer, where it plays a critical role in diagnosis and monitoring. This technology provides valuable information about cellular characteristics and behavior, making it crucial for understanding disease progression and treatment response. In addition, advancements in cell-based research, including stem cell research and cell therapeutics, contribute significantly to the market growth. These fields require in-depth cellular analysis, and flow cytometry is a key tool to meet these needs. In addition, the growing interest in personalized medicine, which requires precise information at the cellular level to develop individualized treatment strategies, is another driving factor. Moreover, the rise of single-cell analysis in genomics and proteomics is boosting the demand for cell-based flow cytometry, given its capability to analyze individual cells within a population.

Breakup by Application:

Oncology

Drug Discovery

Disease Diagnosis

Stem Cell Therapy

Organ Transplantation

Hematology

Others

Oncology dominates the market

The report has provided a detailed breakup and analysis of the market based on the application. This includes oncology, drug discovery, disease diagnosis, stem cell therapy, organ transplantation, hematology, and others. According to the report, oncology represented the largest segment.

The market in the field of oncology is largely driven by the rising global incidence of cancer and the indispensable role of this method in cancer research and patient management. Flow cytometry provides rapid, detailed analysis of cell populations, making it essential for diagnosing various forms of cancer, particularly hematological malignancies. It is also widely used for monitoring disease progression and response to treatment, thereby contributing to the decision-making process in cancer management. In confluence with this, the esclating adoption of personalized medicine in oncology, which requires high-resolution cellular analysis to develop tailored treatment strategies, further propels the demand for flow cytometry. Additionally, advancements in flow cytometry technology, such as the development of multicolor flow cytometry, have significantly enhanced its capabilities in cancer research.

Breakup by End-User:

Hospitals and Clinics

Academic and Research Institutes

Pharmaceutical and Biotechnology Companies

Others

Hospitals and clinics dominate the market

A detailed breakup and analysis of the market based on the end-user have also been provided in the report. This includes hospitals and clinics, academic and research institutes, pharmaceutical and biotechnology companies, and others. According to the report, cell-based hospitals and clinics represented the largest segment.

The market within hospitals and clinics is being driven by the growing prevalence of diseases that require flow cytometry for diagnosis and monitoring, such as cancers and immunological disorders. As the patient load for these conditions grows, so does the need for rapid, accurate diagnostic tools in these healthcare settings. Moreover, technological advancements have resulted in more compact and user-friendly flow cytometers, making it easier for hospitals and clinics to adopt this technology. The rise of personalized medicine also promotes the use of flow cytometry in these settings, as it provides the detailed cellular analysis needed for personalized treatment strategies. In addition, as this method becomes more recognized for its ability to deliver fast and comprehensive results, insurance providers are increasingly covering flow cytometry-based tests, further promoting its adoption in hospitals and clinics.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest flow cytometry market share

The report has also provided a comprehensive analysis of all the major regional markets, which includes North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and Others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and Others); Latin America (Brazil, Mexico, and Others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The growth of the flow cytometry industry in North America is driven by a well-established healthcare infrastructure and robust research environment, both of which foster the adoption and development of advanced technologies. Along with this, the high incidence of chronic diseases such as cancer, where this method plays a crucial role in diagnosis and monitoring, also contributes to market growth. Additionally, the presence of leading companies in this region supports the development of innovative technologies and applications. Furthermore, the significant investment in research and development, including biomedical research, clinical trials, and drug discovery processes that extensively use flow cytometry, further fuels market growth. The region's growing interest in personalized medicine, which requires detailed cellular analysis provided by flow cytometry, also contributes to the market demand.

Competitive Landscape:

The global flow cytometry market is experiencing significant growth due to the growing investments in research and development to create advanced flow cytometry technologies. This includes the development of new instruments, reagents, software, and methodologies. These advancements aim to enhance the capabilities of flow cytometry, making it more precise, efficient, and user-friendly. Along with this, the escalating number of strategic partnerships with other businesses, research institutions, and healthcare providers is significantly supporting the market. These collaborations often aim to advance research, develop new applications, and broaden the reach of flow cytometry technology. Apart from this, the manufacturers are introducing education and training services, such as workshops, webinars, or online tutorials to help users fully utilize the potential of flow cytometry in their work. Therefore, it is significantly supporting the market. Moreover, key players are providing strong customer service and technical support, which is creating a positive market outlook.

The report has provided a comprehensive analysis of the competitive landscape in the global flow cytometry market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Agilent Technologies Inc.

Apogee Flow Systems Ltd.

BD (Becton, Dickinson and Company)

Beckman Coulter Inc. (Danaher Corporation)

Bio-RAD Laboratories Inc.

Enzo Life Sciences Inc.

Luminex Corporation

Merck KGaA

Sony Biotechnology Inc.

Sysmex Partec GmbH

Thermo Fisher Scientific Inc.

Recent Developments:

In February 2023, Agilent Technologies Inc. announced the availability of new NovoExpress software, which brings integrated compliance tools for NovoCyte flow cytometer devices.

In June 2023, BD (Becton, Dickinson and Company) announced the global commercial launch of a new automated device that cleans samples for clinical diagnostics using flow cytometry, offering a full "walkaway" workflow solution intended to increase standardisation and repeatability in cellular diagnostics.

In June 2021, Bio-RAD Laboratories Inc. released three StarBright Dyes made for use in flow cytometry. StarBright Violet 570, 670, and 710 Dyes are appropriate for use in multicolor flow cytometry panels because to their enhanced brightness and accurate excitation and emission spectra.

Key Questions Answered in This Report

  • 1. What was the size of the global flow cytometry market in 2023?
  • 2. What is the expected growth rate of the global flow cytometry market during 2024-2032?
  • 3. What are the key factors driving the global flow cytometry market?
  • 4. What has been the impact of COVID-19 on the global flow cytometry market?
  • 5. What is the breakup of the global flow cytometry market based on the product and service?
  • 6. What is the breakup of the global flow cytometry market based on the technology?
  • 7. What is the breakup of the global flow cytometry market based on the application?
  • 8. What is the breakup of the global flow cytometry market based on the end-user?
  • 9. What are the key regions in the global flow cytometry market?
  • 10. Who are the key players/companies in the global flow cytometry market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Flow Cytometry Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product and Service

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Reagents and Consumables
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Accessories
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Software
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Services
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Cell-Based Flow Cytometry
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Bead-Based Flow Cytometry
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Oncology
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Drug Discovery
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Disease Diagnosis
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Stem Cell Therapy
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Organ Transplantation
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Hematology
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Others
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Academic and Research Institutes
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Pharmaceutical and Biotechnology Companies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Agilent Technologies Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Apogee Flow Systems Ltd.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 BD (Becton, Dickinson and Company)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Beckman Coulter Inc. (Danaher Corporation)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 SWOT Analysis
    • 14.3.5 Bio-RAD Laboratories Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Enzo Life Sciences Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Luminex Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Merck KGaA
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Sony Biotechnology Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Sysmex Partec GmbH
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis